Ozone-Oxygen Administration In Cancer Therapy

Main Category: Cancer / Oncology
Article Date: 07 Mar 2008 - 3:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Researchers at the Philipps University Marburg, Campus Marburg, Germany, applied ozone-oxygen by intraperitoneal insufflation for the treatment of rabbit squamous cell carcinomas. This therapy resulted in the complete remission of the cancers in approximately 50% of the animals.

Ozone administration has long been known to inhibit the growth of various carcinoma cells in vitro. This study demonstrates ozone's effectiveness and safety in an in vivo animal model.

The study's data suggests that "the intraperitoneal application of a medical O3/O2 gas mixture (O3/O2-pneumoperitoneum) appears to stimulate the body's own antitumorous immunosurveillance."

Gerard Sunnen, M.D., president of Ozonics International, LLC, states, "If, indeed, as shown in previous studies, internal ozone administration bolsters immune system parameters, such as cytokine and NK cell activation or other yet still unknown ozone-induced substances, these impressive results could imply new treatment considerations, not only for cancers but also for infectious diseases."

This study is to be presented at the 7th International Conference on Head and Neck Cancer, July 19-23, 2008, San Francisco.

Treatment with ozone/oxygen pneumoperitoneum results in complete remission of rabbit squamous cell carcinomas
Schulz S, Häussler U, Mandic R, Heverhagen J, et al.
International Journal of Cancer. Jan 2008 (on-line; to be published March 2008, Wiley-Liss, Inc.).

Ozonics International, LLC